A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Medical Center Groningen
About this trial
to study the anti-tumor effect of cannabis oil (THC10% / CBD5%) in untreatable HCC patients based on mRECIST and RECIST criteria
Eligibility criteria
Qualifiers
Age =>18 yrs
Histologically proven hepatocellular carcinoma
Non-cirrhosis or Child Pugh A cirrhosis
Hepatic encephalopathy grade 0 or 1
Disqualifiers
Child Pugh B or C cirrhosis
Hepatic encephalopathy grade 2 or more
Previous systemic treatment for HCC
Mental conditions rendering the subject incapable to understand the nature, scope and consequences of the trial
Trial design
Treatments tested in this trial
- Medical Cannabis
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov